The Lancet Diabetes and Endocrinology
最新影响因子 - 实时趋势预测 & 排名分区分析


最新

影响因子

2019-2020

25.34

3.3%

影响因子趋势分析

The Lancet Diabetes and Endocrinology

The Lancet Diabetes and Endocrinology 2019-2020 年的影响因子为25.34。

最高影响因子
25.34
最高影响因子 IF

近十年The Lancet Diabetes and Endocrinology的最高影响因子为25.34。

最低影响因子
9.185
最低影响因子 IF

近十年The Lancet Diabetes and Endocrinology的最低影响因子为9.185。

影响因子 总成长率
175.9%
影响因子 总成长率

近十年The Lancet Diabetes and Endocrinology的影响因子总成长率为175.9%。

影响因子 平均成长率
29.3%
影响因子 平均成长率

近十年The Lancet Diabetes and Endocrinology的影响因子平均成长率为29.3%。

影响因子排名分区

子领域 分区 排名 百分比
Internal Medicine 1区 1/128

Internal Medicine 99%

Endocrinology, Diabetes and Metabolism 1区 1/217

Endocrinology, Diabetes and Metabolism 99%

Endocrinology 1区 1/118

Endocrinology 99%

影响因子排名分区

· 在Internal Medicine研究领域,The Lancet Diabetes and Endocrinology的分区数为1区。The Lancet Diabetes and Endocrinology在Internal Medicine研究类别的128种相关期刊中排名第1。在Internal Medicine领域,The Lancet Diabetes and Endocrinology的排名百分位约为99%。
· 在Endocrinology, Diabetes and Metabolism研究领域,The Lancet Diabetes and Endocrinology的分区数为1区。The Lancet Diabetes and Endocrinology在Endocrinology, Diabetes and Metabolism研究类别的217种相关期刊中排名第1。在Endocrinology, Diabetes and Metabolism领域,The Lancet Diabetes and Endocrinology的排名百分位约为99%。
· 在Endocrinology研究领域,The Lancet Diabetes and Endocrinology的分区数为1区。The Lancet Diabetes and Endocrinology在Endocrinology研究类别的118种相关期刊中排名第1。在Endocrinology领域,The Lancet Diabetes and Endocrinology的排名百分位约为99%。

国际合作趋势

引用文献趋势

影响因子历年数据分析

影响因子
影响因子
2019-2020 25.34
2018-2019 24.54
2017-2018 19.313
2016-2017 19.742
2015-2016 16.32
2014-2015 9.185
2013-2014 -
2012-2013 -
2011-2012 -
影响因子历年数据分析

· The Lancet Diabetes and Endocrinology 2019-2020年的影响因子为25.34
· The Lancet Diabetes and Endocrinology 2018-2019年的影响因子为24.54
· The Lancet Diabetes and Endocrinology 2017-2018年的影响因子为19.313
· The Lancet Diabetes and Endocrinology 2016-2017年的影响因子为19.742
· The Lancet Diabetes and Endocrinology 2015-2016年的影响因子为16.32
· The Lancet Diabetes and Endocrinology 2014-2015年的影响因子为9.185
The Lancet Diabetes and Endocrinology2013-2014的影响因子仍在等待计算中,敬请关注!
The Lancet Diabetes and Endocrinology2012-2013的影响因子仍在等待计算中,敬请关注!
The Lancet Diabetes and Endocrinology2011-2012的影响因子仍在等待计算中,敬请关注!

The Lancet Diabetes and Endocrinology
基本资讯
The Lancet Diabetes and Endocrinology | Academic Accelerator - About the Journal

介绍

Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.

ISSN
2213-8587
ISSN

The Lancet Diabetes and Endocrinology的ISSN是 2213-8587 ISSN是一个8位数的代码,用于识别各种报纸,期刊,杂志和期刊以及所有媒体 - 包括印刷版和电子版。

ISSN (Online)
2213-8595
ISSN (Online)

The Lancet Diabetes and Endocrinology的ISSN(Online)是 2213-8595 . ISSN是一个8位数的代码,用于识别各种报纸,期刊,杂志和期刊以及所有媒体 - 包括印刷版和电子版。

出版社
Elsevier BV
出版社

The Lancet Diabetes and Endocrinology的出版社是 Elsevier BV

出版频率
-
出版频率

The Lancet Diabetes and Endocrinology publishes reports - .

出版年度
2013 - Present
出版年度

The Lancet Diabetes and Endocrinology的出版年度包含 2013 - Present .

开放存取
NO
开放存取

The Lancet Diabetes and Endocrinology传统订阅 (non-OA) 期刊。出版商拥有其期刊中文章的版权。任何想要阅读文章的人都应该由个人或机构支付费用来访问这些文章。任何人想以任何方式使用这些文章都必须获得出版商的许可。

出版费
Review
出版费

There is no publication fee for submiting manuscript to The Lancet Diabetes and Endocrinology. The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

语言
-
语言

The language of The Lancet Diabetes and Endocrinology is - .

国家/地区
Netherlands
国家/地区

The publisher of The Lancet Diabetes and Endocrinology is Elsevier BV , which locates in Netherlands .

What is Impact Factor?

The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.

The Lancet Diabetes and Endocrinology | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The The Lancet Diabetes and Endocrinology Journal Impact IF measures the average number of citations received in a particular year (2020) by papers published in the The Lancet Diabetes and Endocrinology during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of The Lancet Diabetes and Endocrinology.

什么是影响因子?

影响因子(IF)经常用作表明期刊对其领域重要性的指标。它是由科学信息研究所的创始人Eugene Garfield首次提出的。尽管IF被机构和临床医生广泛使用,但是人们对于IF日记的计算方法,其意义以及如何利用它存在着广泛的误解。期刊的影响因子与同行评议过程的质量和期刊的内容质量等因素无关,而是一种反映对期刊,书籍,论文,项目报告,报纸上发表的文章的平均引用次数的度量,会议/研讨会论文集,在互联网上发布的文件,说明以及任何其他批准的文件。

The Lancet Diabetes and Endocrinology | Academic Accelerator - About the Impact Factor

影响因子通常用于评估期刊在其领域内的相对重要性,以及衡量期刊在特定时间段内引用“平均文章”的频率。发表更多评论文章的期刊将获得最高的IF。 IF较高的期刊被认为比IF较低的期刊更重要。根据尤金·加菲尔德(Eugene Garfield)的说法,“影响只是反映期刊和编辑吸引最佳论文的能力。”发表更多评论文章的期刊将获得最大的IF。